Company
Leviathan Cannabis Group, Inc.
Headquarters: Toronto, ON, Canada
CEO: Ms. Tanvi Bhandari
Market Cap
C$29.4 Million
CAD as of Jan. 1, 2025
US$20.5 Million
Leviathan Cannabis Group, Inc. Categories
Canada Healthcare Drug Manufacturers—Specialty & GenericCanada Healthcare Canada Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Leviathan Natural Products Inc. engages in cultivating, processing, and distributing of non-psychoactive, hemp-derived cannabinoid products for the health and wellness market in Canada, the United States, Colombia, and South America. It operates through Marketing, Cultivation, and Investment segments. The company operates a cannabis and hemp cultivation and processing facility; owns a greenhouse infrastructure in Pelham, Ontario; and offers marketing services to the cannabis/hemp sector. The company was formerly known as Leviathan Cannabis Group Inc. Leviathan Natural Products Inc. was incorporated in 2011 and is headquartered in Toronto, Canada.
Stocks & Indices
Leviathan Cannabis Group, Inc. has the following listings and related stock indices.
Stock: CSE: EPIC wb_incandescent
Stock: OTC: LVCNF wb_incandescent